Recent developments in therapeutic applications of Cyanobacteria

References

• Aherne G, Hardcastle A, Valenti M, et al. (1996). Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay. Cancer Chemother Pharmacol 38:225–32
   PubMed Web of Science ®Google Scholar
• Balskus EP, Walsh CT. (2010). The genetic and molecular basis for sunscreen biosynthesis in cyanobacteria. Science 24:1653–6
   Web of Science ®Google Scholar
• Balunas MJ, Linington RG, Tidgewell K, et al. (2010). Dragonamide E, a modified linear lipo-peptide from Lyngbya majuscula with antileishmanial activity. J Nat Prod 73:60–6
   PubMed Web of Science ®Google Scholar
• Balzarini J. (2007). Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses? Antivir Chem Chemother 18:1–11
   PubMedGoogle Scholar
• Banker R, Carmeli S. (1999). Inhibitors of serine proteases from a waterbloom of the cyanobacterium, Microcystis sp. Tetrahedron 55:10835–44
   Web of Science ®Google Scholar
• Baran PS, Richter JM. (2005). Enantioselective total syntheses of welwitindolinone A and fischerindoles I and G. J Am Chem Soc 127:15394–6
   PubMed Web of Science ®Google Scholar
• Barrientos LG, O'Keefe BR, Bray M, et al. (2003). Cyanovirin-N binds to the viral surface glycoprotein, GP1, 2 and inhibits infectivity of Ebola virus. Antiviral Res 58:47–56
   PubMed Web of Science ®Google Scholar
• Barrios-Llerena ME, Burja AM, Wright PC. (2007). Genetic analysis of polyketide synthase and peptide synthetase genes in cyanobacteria as a mining tool for secondary metabolites. J Ind Microbiol Biotechnol 34:443–56
   PubMed Web of Science ®Google Scholar
• Beckwith M, Urba WJ, Longo DL. (1993). Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15. J Natl Cancer Inst 85:483–8
   PubMed Web of Science ®Google Scholar
• Begley M, Cotter PD, Hill C, Ross RP. (2009). Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl Environ Microbiol 75:5451–60
   PubMed Web of Science ®Google Scholar
• Bhaskar SU, Gopalswamy G, Raghu R. (2005). A simple method for efficient extraction and purification of C-phycocyanin from Spirulina platensis Geitler. Indian J Exp Biol 43:277–9
   PubMedGoogle Scholar
• Bierbaum G, Sahl HG. (2009). Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol 10:2–18
   PubMed Web of Science ®Google Scholar
• Bokesch HR, Barry R, O'Keefe Tawnya C, et al. (2003). A potent novel anti-HIV protein from the cultured Cyanobacterium Scytonema varium. Biochemistry 42:2578–84
   PubMed Web of Science ®Google Scholar
• Borowitzka MA. (1998). Algae as food. In: Wood BJB, ed. Microbiology of fermented foods 2. London, UK: Blackie Academic and Professional, 585–602
   Google Scholar
• Boudreau PD, Byrum T, Liu WT, et al. (2012). Viequeamide A, a cytotoxic member of the kulolide superfamily of cyclic depsipeptides from a marine button cyanobacterium. J Nat Prod 75:1560–70
   PubMed Web of Science ®Google Scholar
• Boyd MR, Gustafson KR, McMahon JB, et al. (1997). Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob Agents Chemother 41:1521–30
   PubMed Web of Science ®Google Scholar
• Buffa V, Stieh D, Mamhood N, et al. (2009). Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models. J General Virol 90:234–43
   PubMed Web of Science ®Google Scholar
• Burja AM, Banaigs EB, Abou-Mansour Burgess JG, Wright PC. (2001). Marine cyanobacteria-a prolific source of natural products. Tetrahedron 57:9347–77
   Web of Science ®Google Scholar
• Burja AM, Dhamwichukorn S, Wright PC. (2003). Cyanobacterial postgenomic research and systems biology. Trends Biotechnol 21:504–11
   PubMed Web of Science ®Google Scholar
• Challem JJ, Passwater RA, Mindell EM. (1981). Spirulina. New Canaan, CT: Keats Publishing Inc
   Google Scholar
• Chen QY, Liu Y, Cai W, Luesch H. (2014). Improved total synthesis and biological evaluation of potent apratoxin S4 based anticancer agents with differential stability and further enhanced activity. J Med Chem 57:3011–29
   PubMed Web of Science ®Google Scholar
• Choi H, Mevers E, Byrum T, et al. (2012). Lyngbyabellins K-N from Two Palmyra Atoll Collections of the Marine Cyanobacterium Moorea bouillonii. European J Org Chem 2012:5141–50
   PubMed Web of Science ®Google Scholar
• Ciferri O. (1983). Spirulina, the edible microorganism. Microbiol Rev 47:551–78
   PubMedGoogle Scholar
• Cohen Z, Reungjit Chachawali MW, Siangdung W, Tanticharoen M. (1993). Production and partial purification of γ-Linolenic acid and some pigments from Spirulina platensis. J Appl Phycol 5:109–15
   Web of Science ®Google Scholar
• D’Agostino G, Del Campo J, Mellado B, et al. (2006). A Multicenter phase ii study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer. Int J Gynecol Cancer 16:71–6
   PubMed Web of Science ®Google Scholar
• De la Coba F, Aguilera J, de Galvez MV, et al. (2009). Prevention of the ultraviolet effects on clinical and histopathological changes, as well as the heat shock protein70 expression in mouse skin by topical application of algal UV absorbing compounds. J Dermatol Sci 55:161–9
   PubMed Web of Science ®Google Scholar
• Doan NT, Stewart PR, Smith GD. (2001). Inhibition of bacterial RNA polymerase by the cyanobacterial metabolites 12-epi-hapalindole E isonitrile and calothrixin A. FEMS Microbiol Lett 196:135–9
   PubMed Web of Science ®Google Scholar
• Donia MS, Ravel J, Schmidt EW. (2008). A global assembly line for cyanobactins. Nat Chem Biol 4:341–3
   PubMed Web of Science ®Google Scholar
• Edelman MJ, Gandara DR, Hausner P, et al. (2003). Phase 2 study of cryptophycin 52 (LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer. Lung Cancer 39:197–9
   PubMed Web of Science ®Google Scholar
• Eriksen NT. (2008). Production of phycocyanin-a pigment with applications in biology, biotechnology, foods and medicine. Appl Microbiol Biotechnol 80:1–14
   PubMed Web of Science ®Google Scholar
• Esser MT, Mori T, Mondor I, et al. (1999). Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. J Virol 73:4360–71
   PubMed Web of Science ®Google Scholar
• Euler US, Eliassen R. (1967). Prostaglandins. New York: Academic Press
   Google Scholar
• Fujimoto YK, Green DF. (2012). Carbohydrate recognition by the antiviral lectin cyanovirin-N. J Am Chem Soc 134:19639–51
   PubMed Web of Science ®Google Scholar
• Fujimoto YK, TerBush RN, Patsalo V, Green DF. (2008). Computational models explain the oligosaccharide specificity of cyanovirin-N. Protein Sci 17:2008–14
   PubMed Web of Science ®Google Scholar
• Goto Y, Li B, Claesen J, et al. (2010). Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights. PLoS Biol 8: e1000339
   PubMed Web of Science ®Google Scholar
• Grach-Pogrebinsky O, Sedmak B, Carmeli S. (2003). Protease inhibitors from Slovenian Lake Bled toxic waterbloom of the cyanobacterium, Planktothrix rubescens. Tetrahedron 59:8329–36
   Web of Science ®Google Scholar
• Gutiérrez M, Suyama TL, Engene N, et al. (2008). Apratoxin D, a potent cytotoxic cyclodepsipeptide from papua new guinea collections of the marine cyanobacteria Lyngbya majuscula and Lyngbya sordida. J Nat Prod 71:1099–103
   PubMed Web of Science ®Google Scholar
• Habib MAB, Parvin M, Huntington TC, Hasan MR. (2008). A review on culture and production and use of Spirulina as food for humans and feeds for domestic animals and fish. FAO Fischeries and Aquaculture Circular No. 1034, Rome, Food and Agriculture Organisation of the United Nations, 41 p
   Google Scholar
• Hayashi O, Hirahashi T, Katoh T, et al. (1998). Class-specific influence of dietary Spirulina platensis on antibody production in mice. J Nutr Sci Vitaminol 44:841–51
   PubMed Web of Science ®Google Scholar
• Helle F, Wychowski C, Vu-Dac N, et al. (2006). Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans. J Biol Chem 281:25177–83
   PubMed Web of Science ®Google Scholar
• Horrobin DF. (2000). Essential fatty acid metabolism and its modification in atopic eczema. Am J Clin Nutr 71:367s–72s
   PubMed Web of Science ®Google Scholar
• Iménez JI, Scheuer PJ. (2001). New lipopeptides from the Caribbean cyanobacterium, Lyngbya majuscula. J Nat Prod 64:200–3
   PubMed Web of Science ®Google Scholar
• Jenke-Kodama H, Sandmann A, Müller R, Dittmann E. (2005). Evolutionary implications of bacterial polyketide synthases. Mol Biol Evol 22:2027–39
   PubMed Web of Science ®Google Scholar
• Jensen GS, Ginsberg DI, Huerta P, et al. (2000). Consumption of Aphanizomenon flos aquae has rapid effects on the circulation and function of immune cells in humans. JANA 2:50–8
   Google Scholar
• Kajiyama S, Kanzaki H, Kawazu K, Kobayashi A. (1998). Nostofungicidine, an antifungal lipopeptide from the field-grown terrestrial blue-green alga, Nostoc commune. Tetrahedron Lett 39:3737–40
   Web of Science ®Google Scholar
• Kapuścik A, Hrouzek P, Kuzma M, et al. (2013). Novel Aeruginosin-865 from Nostoc sp. as a potent anti-inflammatory agent. Chem Biochem 14:2329–37
   Google Scholar
• Kerbrat P, Dieras VNP, Ravaud A, et al. (2003). Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer. Eur J Cancer 39:317–20
   PubMed Web of Science ®Google Scholar
• Kernoff PBA, Willis AL, Stone KJ, et al. (1977). Antithrombotic potential of dihomo-gamma-linolenic acid in man. Br Med J 2:1441–4
   PubMed Web of Science ®Google Scholar
• Kim H, Lantvit D, Hwang C-H, et al. (2012). Indole alkaloids from two cultured cyanobacteria, Westiellopsis sp. and Fischerella muscicola. Bioorg Med Chem 20:5290–5
   PubMed Web of Science ®Google Scholar
• Koglin A, Walsh CT. (2009). Highlight: structural insights into nonribosomal peptide enzymatic assembly lines. Nat Prod Rep 26:987–1000
   PubMed Web of Science ®Google Scholar
• Kronick MN, Grossman PD. (1983). Immunoassay techniques with fluorescent phycobiliprotein conjugates. Clin Chem 29:1582–6
   PubMed Web of Science ®Google Scholar
• Ku CS, Pham TX, Park Y, et al. (2013). Edible blue-green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-κB pathway in macrophages and splenocytes. Biochim Biophys Acta 1830:2981–8
   PubMed Web of Science ®Google Scholar
• Kushak R, VanCott E, Drapeau C, Winter H. (1999). Effect of algae, Aphanizomenon flos-aquae on digestive enzyme activity and polyunsaturated fatty acids level in blood plasma. Gastroenterology 116:A559
   Google Scholar
• Kwan JC, Eksioglu EA, Liu C, et al. (2009). Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation. J Med Chem 52:5732–47
   PubMed Web of Science ®Google Scholar
• Kwan JC, Ratnayake R, Abboud KA, et al. (2010). Grassypeptolides A-C, cytotoxic bis-thiazoline containing marine cyclodepsipeptides. J Org Chem 75:8012–23
   PubMed Web of Science ®Google Scholar
• Leung P, Lee H, Kung Y, et al. (2013). Therapeutic effect of C-phycocyanin extracted from blue green algae in a rat model of acute lung injury induced by lipopolysaccharide. Evid Based Complement Alternat Med 11:916590
   Google Scholar
• Li B, Sher D, Kelly L, et al. (2010). Catalytic promiscuity in the biosynthesis of cyclic peptide secondary metabolites in planktonic marine cyanobacteria. Proc Natl Acad Sci USA 107:10430–5
   PubMed Web of Science ®Google Scholar
• Liang J, Moore RE, Moher ED, et al. (2005). Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors. Invest New Drugs 23:213–24
   PubMed Web of Science ®Google Scholar
• Liu Y, Law BK, Luesch H. (2009). Apratoxin A reversibly inhibits the secretory pathway by preventing cotranslational translocation. Mol Pharmacol 76:91–104
   PubMed Web of Science ®Google Scholar
• Luesch H, Chanda SK, Raya RM, et al. (2006). A functional genomics approach to the mode of action of apratoxin A. Nat Chem Biol 2:158–67
   PubMed Web of Science ®Google Scholar
• Luesch H, Yoshida WY, Moore RE, et al. (2001). Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium, Lyngbya majuscula. J Am Chem Soc 123:5418–23
   PubMed Web of Science ®Google Scholar
• Matern U, Oberer L, Falchetto RA, et al. (2001). Scyptolin A and B, cyclic depsipeptides from axenic cultures of Scytonema hofmanni PCC 7110. Phytochemistry 58:1087–95
   PubMed Web of Science ®Google Scholar
• Mathew B, Sankaranarayanan R, Nair PP, et al. (1995). Evaluation of chemoprevention of oral cancer with Spirulina fusiformis. Nutr Cancer 24:197–202
   PubMed Web of Science ®Google Scholar
• Matthew S, Paul VJ, Luesch H. (2009a). Largamides A-C, tiglic acid-containing cyclodepsipeptides with elastase-inhibitory activity from the marine cyanobacterium, Lyngbya confervoides. Planta Med 75:528–33
   PubMed Web of Science ®Google Scholar
• Matthew S, Paul VJ, Luesch H. (2009b). Tiglicamides A-C, cyclodepsipeptides from the marine cyanobacterium Lyngbya confervoides. Phytochemistry 70:2058–63
   PubMed Web of Science ®Google Scholar
• Matthew S, Ross C, Rocca JR, et al. (2007). Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides. J Nat Prod 70:124–7
   PubMed Web of Science ®Google Scholar
• McPhail KL, Correa J, Linington RG, et al. (2007). Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula. J Nat Prod 70:984–8
   PubMed Web of Science ®Google Scholar
• Mevers E, Haeckl FP, Boudreau PD, et al. (2014). Lipopeptides from the tropical marine cyanobacterium Symploca sp. J Nat Prod 77:969–75
   PubMed Web of Science ®Google Scholar
• Mevers E, Liu WT, Engene N, et al. (2011). Cytotoxic veraguamides, alkynyl bromide-containing cyclic depsipeptides from the marine cyanobacterium cf. Oscillatoria margaritifera. J Nat Prod 74:928–36
   PubMed Web of Science ®Google Scholar
• Mita CA, Schwartz G, Mita MM, et al. (2006). A pilot, pharmacokinetic (PK), and pharmacodynamic (PD) study to determine the feasibility of intrapatient dose escalation to tolerable rash and the activity of maximal doses of erlotinib (E) in previously treated patients with advanced non-small cell lung cancer (NSCLC). J Clin Oncol 23:3045
   Google Scholar
• Mo S, Krunic A, Santarsiero BD, et al. (2010). Hapalindole-related alkaloids from the cultured cyanobacterium Fischerella ambigua. Phytochemistry 71:2116–23
   PubMed Web of Science ®Google Scholar
• Moffitt MC, Louie GV, Bowman ME, et al. (2007). Discovery of two cyanobacterial phenylalanine ammonia lyases: kinetic and structural characterization. Biochemistry 46:1004–12
   PubMed Web of Science ®Google Scholar
• Montaser R, Abboud KA, Paul VJ, Luesch H. (2011b). Pitiprolamide, a proline-rich dolastatin 16 analogue from the marine cyanobacterium Lyngbya majuscula from Guam. J Nat Prod 74:109–12
   PubMed Web of Science ®Google Scholar
• Montaser R, Paul VJ, Luesch H. (2011a). Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam. Phytochemistry 72:2068–74
   PubMed Web of Science ®Google Scholar
• Moon SS, Chen J, Moore RE, Patterson GML. (1992). Calophycin, a fungicidal cyclic decapeptide from the terrestrial blue-green alga Calothrix fusca. J Org Chem 57:1097–103
   Web of Science ®Google Scholar
• Moore RE, Cheuk C, Patterson GML. (1984). Hapalindoles: new alkaloids from the blue-green alga Hapalosiphon fontinalis. J Am Chem Soc 106:6456–7
   Web of Science ®Google Scholar
• Moore RE, Cheuk C, Yang X-QG, et al. (1987). Hapalindoles, antibacterial and antimycotic alkaloids from the cyanophyte Hapalosiphon fontinalis. J Org Chem 52:1036–43
   Web of Science ®Google Scholar
• Murakami M, Okita Y, Matsuda H, et al. (1994). Aeruginosin 298-A, a thrombin and trypsin inhibitor from the blue-green alga, Microcystis aeruginosa (NIES-298). Tetrahedron Lett 35:3129–32
   Web of Science ®Google Scholar
• Nazifi E, Wada N, Yamaba M, et al. (2013). Glycosylated porphyra-334 and palythine-threonine from the terrestrial cyanobacterium Nostoc commune. Mar Drugs 11:3124–54
   PubMed Web of Science ®Google Scholar
• O'Keefe BR, Smee DF, Turpin JA, et al. (2003). Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin. Antimicrob Agents Chemother 47:2518–25
   PubMed Web of Science ®Google Scholar
• Okino T, Matsuda H, Murakami M, Yamaguchi K. (1993). Microginin, an angiotensin converting enzyme inhibitor from the blue-green alga, Microcystis aeruginosa. Tetrahedron Lett 34:501–4
   Web of Science ®Google Scholar
• O'Sullivan O, Begley M, Ross RP, et al. (2011). Further identification of novel lantibiotic operons using LanM-based genome mining. Prob Antimicrob Prot 3:27–40
   PubMed Web of Science ®Google Scholar
• Oyamada C, Kaneniwa M, Ebitani K, et al. (2008). Mycosporine like amino acids extracted from scallop (Patinopecten yessoensis) ovaries: UV protection and growth stimulation activities on human cells. Mar Biotechnol (NY) 10:141–50
   PubMed Web of Science ®Google Scholar
• Pabon MM, Jernberg JN, Morganti J, et al. (2012). A spirulina-enhanced diet provides neuroprotection in an alpha-synuclein model of Parkinson's disease. PLoS One 7:e45256
   PubMed Web of Science ®Google Scholar
• Paylik CM, Christina Y, Wong B, et al. (2013). Santacruzamate A, a potent and selective histone deacetylase inhibitor from the panamanian marine cyanobacterium cf. Symploca sp. J Nat Prod 76:2026–33
   PubMed Web of Science ®Google Scholar
• Pugh N, Ross SA, ElSohly HN, et al. (2001). Isolation of three high molecular weight poly-saccharide preparations with potent immunostimulatory activity from Spirulina platensis, Aphanizomenon flos-aquae, and Chlorella pyrenoidosa. Plant Med 67:737–42
   PubMed Web of Science ®Google Scholar
• Qiang H, Zhengyu H, Cohen Z, Richmond A. (1997). Enhancement of eicosapentaenoic acid (EPA) and gamma-linolenic acid (GLA) production by manipulating algal density of outdoor cultures of Monodus subterraneus (Eustigmatophyta) and Spirulina platensis (Cyanobacteria). Eur J Phycol 32:81–6
   Web of Science ®Google Scholar
• Qiu B, Liu J, Liu Z, Liu S. (2002). Distribution and ecology of the edible cyanobacterium GeXian-Mi (Nostoc) in rice fields of Hefeng County in China. J Appl Phycol 14:423–9
   Web of Science ®Google Scholar
• Rasmussen HE, Blobaum KR, Jesch ED, et al. (2009). Hypocholesterolemic effect of Nostoc commune var. sphaeroides Kutzing, an edible blue-green alga. Eur J Nutr 48:387–94
   PubMed Web of Science ®Google Scholar
• Rasmussen HE, Blobaum KR, Park Y-K, et al. (2008). Lipid extract of Nostoc commune var. sphaeroides Kutzing, a blue-green alga, inhibits the activation of sterol regulatory element binding proteins in hepG2 Cells. J Nutr 138:476–81
   PubMed Web of Science ®Google Scholar
• Rastogi RP, Incharoensakdi A. (2014a). UV radiation-induced biosynthesis, stability and antioxidant activity of mycosporine-like amino acids (MAAs) in a unicellular cyanobacterium Gloeocapsa sp. CU2556. J Photochem Photobiol B 5:287–92
   Web of Science ®Google Scholar
• Rastogi RP, Incharoensakdi A. (2014b). Characterization of UV-screening compounds, mycosporine-like amino acids, and scytonemin in the cyanobacterium Lyngbya sp. CU2555. FEMS Microbiol Ecol 87:244–56
   PubMed Web of Science ®Google Scholar
• Rastogi RP, Sinha RP, Incharoensakdi A. (2013). Partial characterization, UV-induction and photoprotective function of sunscreen pigment, scytonemin from Rivularia sp. HKAR-4, Chemosphere 93:1874–8
   PubMed Web of Science ®Google Scholar
• Raveh A, Carmeli S. (2010). Aeruginazole A, a novel thiazole-containing cyclopeptide from the cyanobacterium Microcystis sp. Org Lett 12:3536–9
   PubMed Web of Science ®Google Scholar
• Ray A, Okouneva T, Manna T, et al. (2007). Mechanism of action of the microtubule-targeted antimitotic depsipeptide tasidotin (formerly ILX651) and its major metabolite tasidotin C-carboxylate. Cancer Res 67:3767–76
   PubMed Web of Science ®Google Scholar
• Reddy AS, Thomas TL. (1996). Expression of a cyanobacterial Δ6-desaturase gene results in γ-linolenic acid production in transgenic plants. Nat Biotechnol 14:639–42
   PubMed Web of Science ®Google Scholar
• Reddy CM, Bhat VB, Kiranmai G, et al. (2000). Selective inhibition of cyclooxygenase-2 by C-phycocyanin, a biliprotein from Spirulina platensis. Biochem Biophys Res Commun 277:599–603
   PubMed Web of Science ®Google Scholar
• Riely GJ, Gadgeel S, Rothman I, et al. (2007). A phase 2 study of TZT1027, administered weekly to patients with advanced non-small cell lung cancer following treatment with platinum-based chemotherapy. Lung Cancer 55:181–5
   PubMed Web of Science ®Google Scholar
• Rimbau V, Camins A, Pubill D, et al. (2001). C-phycocyanin protects cerebellar granule cells from low potassium/serum deprivation induced apoptosis. Arch Pharmacol 364:96–104
   Web of Science ®Google Scholar
• Romay Ch, González R, Ledón N, et al. (2003). C-phycocyanin: abiliprotein with antioxidant, anti-inflammatory and neuroprotective effects. Curr Protein Pept Sci 4:207–16
   PubMed Web of Science ®Google Scholar
• Salvador LA, Biggs JS, Paul VJ, Luesch H. (2011). Veraguamides A-G, cyclic hexadepsipeptides from a dolastatin 16-producing cyanobacterium Symploca cf. hydnoides from Guam. J Nat Prod 74:917–27
   PubMed Web of Science ®Google Scholar
• Sanchez LM, Lopez D, Vesely BA, et al. (2010). Almiramides A-C: discovery and development of a new class of leishmaniasis lead compounds. J Med Chem 53:4187–97
   PubMed Web of Science ®Google Scholar
• Schmidt EW, Nelson JT, Rasko DA, et al. (2005). Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni, the cyanobacterial symbiont of Lisso-clinum patella. Proc Natl Acad Sci USA 102:7315–20
   PubMed Web of Science ®Google Scholar
• Schwartz RE, Hirsch CF, Sigmund JM, Pettibone DJ. (1989). Hapalindolinone compounds as vasopressin antagonists us patent 4803217. Official Gazette of The United States Patent & Trademark Office Patents, 1099:32
   Google Scholar
• Seshadri CV. (1993). All India coordinated project on Spirulina. Chennai, India: Shri Amm Murugappa Chettiar Research Center (MCRC)
   Google Scholar
• Shi Y, Yang X, Garg N, van der Donk WA. (2011). Production of lantipeptides in Escherichia coli. J Am Chem Soc 133:2338–41
   PubMed Web of Science ®Google Scholar
• Singh S, Kate BN, Banerjee UC. (2005). Bioactive compounds from cyanobacteria and microalgae: an overview. Crit Rev Biotechnol 25:73–95
   PubMed Web of Science ®Google Scholar
• Singh SP, Klisch M, Sinha RP, Häder DP. (2010). Genome mining of mycosporine-like amino acid (MAA) synthesizing and non-synthesizing cyanobacteria: a bioinformatics study. Genomics 2:120–8
   Web of Science ®Google Scholar
• Smith CD, Zilfou JT, Stratmann K, et al. (1995). Welwitindolinone analogues that reverse P-glycoprotein-mediated multiple drug resistance. Mol Pharmacol 47:241–7
   Google Scholar
• Soule T, Palmer K, Gao Q, et al. (2009). A comparative genomics approach to understanding the biosynthesis of the sunscreen scytonemin in cyanobacteria. BMC Genomics 10:336
   PubMed Web of Science ®Google Scholar
• Soule T, Stout V, Swingley WD, et al. (2007). Molecular genetics and genomic analysis of scytonemin biosynthesis in Nostoc punctiforme ATCC 29133. J Bacteriol 189:4465–72
   PubMed Web of Science ®Google Scholar
• Staunton J, Weissman KJ. (2001). Polyketide biosynthesis: a millennium review. Nat Prod Rep 18:380–416
   PubMed Web of Science ®Google Scholar
• Stevenson CS, Capper EA, Roshak AK, et al. (2002a). The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophore. J Pharmacol Exp Ther 303:858–66
   PubMed Web of Science ®Google Scholar
• Stevenson CS, Capper EA, Roshak AK, et al. (2002b). Scytonemin-a marine natural product inhibitor of kinases key in hyperproliferative inflammatory diseases. Inflamm Res 51:112–14
   PubMed Web of Science ®Google Scholar
• Sudek S, Haygood MG, Youssef DTA, Schmidt EW. (2006). Structure of trichamide, a cyclic peptide from the bloom-forming cyanobacterium Trichodesmium erythraeum, predicted from the genome sequence. Appl Environ Microbiol 72:4382–7
   PubMed Web of Science ®Google Scholar
• Supko J, Lynch T, Clark J, et al. (2000). A phase I clinical and pharmacokinetic study of the dolastatin analogue cemadotin administered as a 5-day continuous intrave- nous infusion. Cancer Chemother Pharmacol 46:319–28
   PubMed Web of Science ®Google Scholar
• Tan LT, Okino T, Gerwick WH. (2013). Bouillonamide: a mixed polyketide-peptide cytotoxin from the marine cyanobacterium Moorea bouillonii. Mar Drugs 11:3015–24
   PubMed Web of Science ®Google Scholar
• Tan LT. (2010). Filamentous tropical marine cyanobacteria: a rich source of natural products for anticancer drug discovery. J Appl Phycol 22:659–76
   Web of Science ®Google Scholar
• Taori K, Matthew S, Rocca JR, et al. (2007). Lyngbyastatins 5-7, potent elastase inhibitors from Floridian marine cyanobacteria, Lyngbya sp. J Nat Prod 70:1593–600
   PubMed Web of Science ®Google Scholar
• Torres-Duran PV, Ferreira-Hermosillo A, Juarez-Oropeza MA. (2007). Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report. Lipids Health Dis 6:1–8
   PubMed Web of Science ®Google Scholar
• Tripathi A, Puddick J, Prinsep MR, et al. (2009). Hantupeptin A, a cytotoxic cyclic depsipeptide from a Singapore collection of Lyngbya majuscula. J Nat Prod 72:29–32
   PubMed Web of Science ®Google Scholar
• Tripathi A, Puddick J, Prinsep MR, et al. (2010). Lagunamides A and B: cytotoxic and antimalarial cyclodepsipeptides from the marine cyanobacterium, Lyngbya majuscula. J Nat Prod 73:1810–14
   PubMed Web of Science ®Google Scholar
• Tripathi A, Puddick J, Prinsep MR, et al. (2011). Lagunamide C, a cytotoxic cyclodepsipeptide from the marine cyanobacterium Lyngbya majuscula. Phytochemistry 72:2369–75
   PubMed Web of Science ®Google Scholar
• Valencia A, Walker J. (1999). A multi-axial treatment paradigm for mild traumatic brain injury to achieve reparative functional metaplasticity, 3rd World Congress on brain injury, IBIA, Quebec, Canada
   Google Scholar
• Vasas G, Borbely G, Nánási P, Nánási PP. (2010). Alkaloids from cyanobacteria with diverse powerful bioactivities. Mini Rev Med Chem 10:946–55
   PubMed Web of Science ®Google Scholar
• Vestola J, Shishido TK, Jokela J, et al. (2014). Hassallidins, antifungal glycolipopeptides, are widespread among cyanobacteria and are the end-product of a nonribosomal pathway. Proc Natl Acad Sci USA 111:E1909–17
   PubMed Web of Science ®Google Scholar
• Volkmann M, Gorbushina AA, Kedar L, Oren A. (2006). Structure of euhalothece-362, a novel red-shifted mycosporine-like amino acid, from a halophilic cyanobacterium, (Euhalothece sp). Microbiol Lett 258:50–4
   PubMed Web of Science ®Google Scholar
• Vonshak A. (1997). Spirulina: growth, physiology and biochemistry. In: Vonshak A, ed. Spirulina platensis (Arthrospira): physiology, cell-biology and biotechnology. London, UK: Taylor & Francis, 43–66
   Google Scholar
• Wang H, Fewer DP, Sivonen K. (2011). Genome mining demonstrates the widespread occurrence of gene clusters encoding bacteriocins in cyanobacteria. PLoS One 6:e22384
   PubMed Web of Science ®Google Scholar
• Watanabe F, Takenaka S, Kittaka-Katsura H, et al. (2002). Characterization and bioavailability of vitamin B12-compounds from edible algae. J Nutr Sci Vitaminol (Tokyo) 48:325–31
   PubMed Web of Science ®Google Scholar
• Watanabe J, Minami M, Kobayashi M. (2006). Antitumor activity of TZT-1027 (soblidotin). Anticancer Res 26:1973–81
   PubMed Web of Science ®Google Scholar
• Zainuddin EN, Jansen R, Nimtz M, et al. (2009). Lyngbyazothrins A-D, antimicrobial cyclic undecapeptides from the cultured Cyanobacterium Lyngbya sp. J Nat Prod 72:1373–8
   PubMed Web of Science ®Google Scholar
• Zhang L, Li L, Wu Q. (2007). Protective effects of mycosporine-like amino acids of Synechocystis sp. PCC 6803 and their partial characterization. J Photochem Photobiol B 86:240–5
   PubMed Web of Science ®Google Scholar
• Zhang X, Smith CD. (1996). Microtubule effects of welwistatin, a cyanobacterial indolinone that circumvents multiple drug resistance. Mol Pharm 49:288
   Web of Science ®Google Scholar
• Ziemert N, Ishida K, Quillardet P, et al. (2008). Microcyclamide biosynthesis in two strains of Microcystis aeruginosa: from structure to genes and vice versa. Appl Environ Microbiol 74:1791–7
   PubMed Web of Science ®Google Scholar
• Ziemert N, Ishida K, Weiz A, et al. (2010). Exploiting the natural diversity of microviridin gene clusters for discovery of novel tricyclic depsipeptides. Appl Environ Microbiol 76:3568–74
   PubMed Web of Science ®Google Scholar